Resumen
Carta editorial recibia para el volumen 2 número 3 de ICTUS, órgano oficial de la Asociación mexicana de Enfermedad Vascular Cerebral.
Referencias
Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, et al. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front. Aging Neurosci. 2021;13:662786. https://doi.org/10.3389/fnagi.2021.662786
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767-83. https://doi.org/10.1016/S1474-4422(20)30221-0
Mainali S, Darsie ME. Neurologic and Neuroscientific Evidence in Aged COVID-19 Patients. Front Aging Neurosci. 2021;23(13):648662. https://doi.org/10.3389/fnagi.2021.648662
Berardelli A, Silani V, Barone P, Calabresi P, Girlanda P, Lopiano L, et al. Neurology and the COVID-19 emergency. Neurol Sci. 2020;41(6):1343-44. https://doi.org/10.1007/s10072-020-04465-8
Josephson SA, Kamel H. Neurology and COVID-19. JAMA. 2020;324(12):1139-40. https://doi.org/10.1001/jama.2020.14254
Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279-84. https://doi.org/10.1136/svn-2020-000431
Fridman S, Bres Bullrich M, Jimenez-Ruiz A, Costantini P, Shah P, Just C, et al. Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases. Neurology. 2020;95(24):e3373-85. https://doi.org/10.1212/WNL.0000000000010851
Nannoni S, De Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021;16(2):137-49. https://doi.org/10.1177/1747493020972922
Gaurav A, Giuseppe L, Brandon Michael. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature. Int J Stroke. 2020;15(4):385-89. https://doi.org/10.1177/1747493020921664
Wang H, Tang X, Fan H, Luo Y, Song Y, Xu Y, et al. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients. Aging. 2020;12(11):10022-34. https://doi.org/10.18632/aging.103335
Camacho E, LoPresti MA, Bruce S, Lin D, Abraham M, Appelboom G, et al. The role of age in intracerebral hemorrhages. J Clin Neurosci. 2015;22(12):1867-70. https://doi.org/10.1016/j.jocn.2015.04.020
Peña Silva RA, Chu Y, Miller JD, Mitchell IJ, Penninger JM, Faraci FM, et al. Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging. Stroke. 2012;43(12):3358-63. https://doi.org/10.1161/STROKEAHA.112.667063
Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368-75. https://doi.org/10.1161/HYPERTENSIONAHA.114.03743
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, De Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci. 2003;100(14):8258-63. https://doi.org/10.1073/pnas.1432869100
Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, et al. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management. Front. Neurol. 2020;11:571996. https://doi.org/10.3389/fneur.2020.571996
Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol. 2002;12(3):358-70. https://doi.org/10.1111/j.1750-3639.2002.tb00450.x
Johansson BB. Hypertension mechanisms causing stroke. Clin Exp Pharmacol Physiol. 1999;26(7):563-5. https://doi.org/10.1046/j.1440-1681.1999.03081.x
Divani A, Liu X, Di Napoli M, Lattanzi S, Ziai W, James M, et al. Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage. Stroke. 2019;50(8):2023-29. https://doi.org/10.1161/STROKEAHA.119.025514
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2021 Ictus